Zobrazeno 1 - 10
of 1 572
pro vyhledávání: '"Buchbinder, EI"'
Autor:
Fishman J; From the NYU Langone, New York, NY., Buchbinder EI; Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Cancer journal (Sudbury, Mass.) [Cancer J] 2024 Mar-Apr 01; Vol. 30 (2), pp. 120-125.
Autor:
Tarantino G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ricker CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Wang A; Harvard Medical School, Boston, MA, USA., Ge W; Harvard Medical School, Boston, MA, USA., Aprati TJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Huang AY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Computational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA, USA., Madha S; Worcester Polytechnic Institute, Worcester, MA, USA.; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA., Chen J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Shi Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Glettig M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Feng CH; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Frederick DT; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Freeman S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Holovatska MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA., Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA., Zimmer L; Department of Dermatology, University HospitalEssen, Essen, Germany., Rösch A; Department of Dermatology, University HospitalEssen, Essen, Germany., Zaremba A; Department of Dermatology, University HospitalEssen, Essen, Germany., Livingstone E; Department of Dermatology, University HospitalEssen, Essen, Germany., Jameson JC; Interfaculty Initiative in Health Policy, Harvard University, Cambridge, MA, USA., Saghafian S; Harvard Kennedy School, Harvard University, Cambridge, MA, USA., Lee A; Department of Surgery and Cancer Immunogenomics Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zhao K; Department of Surgery and Cancer Immunogenomics Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Morris LGT; Department of Surgery and Cancer Immunogenomics Research Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Elmarakeby HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Al-Azhar University, Cairo, Egypt., Schilling B; Department of Dermatology, University HospitalEssen, Essen, Germany.; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany., Giobbie-Hurder A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA., Vokes NI; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA., Flaherty KT; Massachusetts General Hospital, Boston, MA, USA., Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Boland GM; Massachusetts General Hospital, Boston, MA, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Schadendorf D; Department of Dermatology, University HospitalEssen, Essen, Germany., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Publikováno v:
Science advances [Sci Adv] 2024 Nov 29; Vol. 10 (48), pp. eadp4670. Date of Electronic Publication: 2024 Nov 27.
Autor:
Khaddour K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Harvard Medical School, Boston, MA 02115, United States., Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Harvard Medical School, Boston, MA 02115, United States., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Harvard Medical School, Boston, MA 02115, United States., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Harvard Medical School, Boston, MA 02115, United States., Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA 02115, United States., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Harvard Medical School, Boston, MA 02115, United States., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Harvard Medical School, Boston, MA 02115, United States., Insco ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, MA 02115, United States.; Harvard Medical School, Boston, MA 02115, United States.
Publikováno v:
The oncologist [Oncologist] 2024 Nov 06. Date of Electronic Publication: 2024 Nov 06.
Autor:
Huang AY; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Massachusetts Institute of Technology, Cambridge, USA., Burke KP; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Porter R; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Meiger L; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Fatouros P; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Yang J; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Massachusetts Institute of Technology, Cambridge, USA.; Rutgers University, New Brunswick, NJ, USA., Robitschek E; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA., Vokes N; University of Texas MD Anderson Cancer Center, Houston, USA., Ricker C; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA., Rosado V; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Tarantino G; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Chen J; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA., Aprati TJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA., Glettig MC; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; ETH Zürich, Zurich, Switzerland., He Y; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA., Wang C; Massachusetts Institute of Technology, Cambridge, USA., Fu D; Massachusetts Institute of Technology, Cambridge, USA., Ho LL; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Massachusetts Institute of Technology, Cambridge, USA., Galani K; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Massachusetts Institute of Technology, Cambridge, USA., Freeman GJ; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Buchbinder EI; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Stephen Hodi F; Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Kellis M; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Massachusetts Institute of Technology, Cambridge, USA., Boland GM; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Massachusetts General Hospital, Boston, MA, USA., Sharpe AH; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Liu D; Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.
Autor:
Maloney AK; Quinnipiac University Frank H Netter MD School of Medicine, North Haven, Connecticut, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Katukota N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Fogarasi MC; Quinnipiac University Frank H Netter MD School of Medicine, North Haven, Connecticut, USA., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Sussman TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Silk AW; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Insco M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA elizabeth_buchbinder@dfci.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Aug 28; Vol. 12 (8). Date of Electronic Publication: 2024 Aug 28.
Autor:
Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Cohen JV; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Tarantino G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Lian CG; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Haq R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Lawrence DP; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts., Giobbie-Hurder A; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Knoerzer D; BioMed Valley Discoveries, Kansas City, Missouri., Sullivan RJ; Harvard Medical School, Boston, Massachusetts.; Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 May 21; Vol. 4 (5), pp. 1321-1327.
Autor:
Babu S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Chen J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Robitschek E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Baron CS; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., McConnell A; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Wu C; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Dedeilia A; Massachusetts General Hospital (MGH) Cancer Center, Boston, MA, 02114, USA., Sade-Feldman M; Massachusetts General Hospital (MGH) Cancer Center, Boston, MA, 02114, USA., Modhurima R; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Chen KY; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Cox AM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Ludwig CG; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Yang J; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, 02142, USA.; MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, 02139, USA., Kellis M; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, 02142, USA.; MIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, 02139, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Hacohen N; Massachusetts General Hospital (MGH) Cancer Center, Boston, MA, 02114, USA.; Broad Institute of Massachusetts Institute of Technology (MIT), Cambridge, MA, 02142, USA.; Harvard Medical School (HMS), Boston, MA, USA; Department of Immunology, HMS, Boston, MA, 02115, USA., Boland GM; Massachusetts General Hospital (MGH) Cancer Center, Boston, MA, 02114, USA., Abraham BJ; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA., Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Zon LI; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Howard Hughes Medical Institute, Boston, MA, 02115, USA., Insco ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Apr 26. Date of Electronic Publication: 2024 Apr 26.
Autor:
Buchbinder EI, Hodi FS
Publikováno v:
Cancer journal (Sudbury, Mass.) [Cancer J] 2023 Jan-Feb 01; Vol. 29 (1), pp. 15-19.
Autor:
Weber JS; Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA. Electronic address: Jeffrey.Weber@nyulangone.org., Carlino MS; Westmead and Blacktown Hospitals, Melanoma Institute Australia, Sydney, NSW, Australia., Khattak A; Hollywood Private Hospital, Perth, WA, Australia; Edith Cowan University, Perth, WA, Australia., Meniawy T; Saint John of God Subiaco Hospital, Subiaco, WA, Australia., Ansstas G; Washington University School of Medicine, St Louis, MO, USA., Taylor MH; Earle A Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA., Kim KB; California Pacific Medical Center Research Institute, San Francisco, CA, USA., McKean M; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, TN, USA., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Sullivan RJ; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Faries M; The Angeles Clinic and Research Institute, a Cedars-Sinai affiliate, Los Angeles, CA, USA., Tran TT; Smilow Cancer Center at Yale New Haven Hospital, New Haven, CT, USA., Cowey CL; Texas Oncology PA, Dallas, TX, USA., Pecora A; Hackensack University Medical Center, Hackensack, NJ, USA., Shaheen M; The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA., Segar J; University of Arizona, Tucson, AZ, USA., Medina T; University of Colorado Cancer Center, Aurora, CO, USA., Atkinson V; Princess Alexandra Hospital, Brisbane, QLD, Australia., Gibney GT; Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA., Luke JJ; UPMC Hillman Cancer Center, Pittsburgh, PA, USA., Thomas S; Orlando Health Kuhl Avenue, Orlando, FL, USA., Buchbinder EI; Dana-Farber Cancer Institute, Boston, MA, USA., Healy JA; Merck & Co, Rahway, NJ, USA., Huang M; Merck & Co, Rahway, NJ, USA., Morrissey M; Moderna, Cambridge, MA, USA., Feldman I; Moderna, Cambridge, MA, USA., Sehgal V; Moderna, Cambridge, MA, USA., Robert-Tissot C; Moderna, Cambridge, MA, USA., Hou P; Moderna, Cambridge, MA, USA., Zhu L; Moderna, Cambridge, MA, USA., Brown M; Moderna, Cambridge, MA, USA., Aanur P; Moderna, Cambridge, MA, USA., Meehan RS; Moderna, Cambridge, MA, USA., Zaks T; Moderna, Cambridge, MA, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2024 Feb 17; Vol. 403 (10427), pp. 632-644. Date of Electronic Publication: 2024 Jan 18.
Autor:
McCarter KR; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America., Arabelovic S; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Wang X; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Wolfgang T; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Yoshida K; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Qian G; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Kowalski EN; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Vanni KMM; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., LeBoeuf NR; Harvard Medical School, Boston, Massachusetts, United States of America; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America., Buchbinder EI; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America., Gedmintas L; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., MacFarlane LA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Rao DA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Shadick NA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Gravallese EM; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America., Sparks JA; Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, United States of America. Electronic address: jsparks@bwh.harvard.edu.
Publikováno v:
Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2024 Feb; Vol. 64, pp. 152335. Date of Electronic Publication: 2023 Dec 08.